Nicholas “Nick” Diamond focuses his practice on federal and international legal manners within the food,
health care, life sciences, medical device, and technology sectors. He helps clients navigate complex
regulatory and corporate matters across these dynamic sectors in the United States and abroad.
Nick advises on a spectrum of FDA-regulated products. including: animal drugs; cosmetics; drug
compounding; food (both human and animal), beverage, and dietary supplements; human
pharmaceuticals and biotechnology products; medical devices (especially AI/ ML enabled SaMD) and
diagnostics; and vaccines. Nick’s focus also extends to products regulated by other federal agencies, such as
USDA. CPSC, and FTC.
Nick regularly advises clinical laboratories, research institutions. and CROs on FDA-related issues from
preclinical development through post-market activities. His background as a trained bioethicist, combined
with his experience teaching bioethics at leading academic institutions, enhances his ability to assist clients
“with ethical considerations that can emerge during research and product commercialization.